Global Genital Herpes Treatment Market Opportunities & Forecast (2018-2025)-GMI Research

DUBLIN - Nov. 30, 2018 - PRLog -- Global Genital Herpes Treatment Market By Drug Type (Acyclovir, Valacyclovir, and Famciclovir), By Route of Administration (Oral, Topical and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Pharmacies, and Drug Stores) and by Geography – Opportunities & Forecast, 2018-2025

Genital herpes is a sexually transmitted disease which is caused by a viral pathogen, herpes simplex virus (HSV) which is carried out via infected people's semen, saliva, and vaginal secretions.HSV-1 and HSV-2 are two types of herpes simplex viruses. The common symptoms of genital herpes are blisters on genital organs, itchiness or tingling in the infected areas, pelvic pain, vaginal discharge, etc. Various types of genital herpes treatments are medication, episodic treatment, and suppressive treatment, etc. Antiviral drugs such as Acyclovir, Famciclovir, and Valacyclovir are commercially available drugs that are used for the treatment genital herpes.

Increasing prevalence of sexually transmitted disease especially genital herpes across the globe is expected to boost the demand of genital herpes treatment over the forecast period. For instance, according to center for disease control and prevention approximately 50.0 million population affected with genital herpes in the U.S. Factors such as rising diagnosis rate in emerging countries and increasing clinical trial of vaccines for genital herpes are also driving the growth of the genital herpes market during the forecast period.

Moreover, increasing awareness about sexually transmitted diseases and rise in government funding to develop innovative therapeutic for the genital herpes treatment spur the market growth during the forecast period. In addition, Accurate diagnostic tests such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, real-time PCR assay are extensively used to diagnose STIs in developed countries. These tests are useful for the diagnosis of asymptomatic infections which would increase the demand for genital herpes treatment and drive the market. However, inadequate reimbursement and low treatment seeking rate for genital herpes, are some of the factors which hinder the growth of the market.

Various notable players operating in the market, include Novartis AG, GlaxoSmithKline,  Genocea Biosciences, AiCuris,     Vical, Maruho, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.,, Apotheca Inc., Sandoz Inc., Hospira Inc., Novopharm Ltd., Dr. Reddy's Laboratories Ltd .among others. Major players are focussing research and development activities to launch innovative therapeutic for the treatment of genital herpes. For instance, GEN-003 vaccines are currently under phase 3 of a clinical trial for the treatment of genital herpes infections.

The global genital herpes treatment market has been segmented on the basis of drug type, route of administration, distribution channel and key geographies. Based on drug type, the market comprises Acyclovir, Valacyclovir, and Famciclovir. The research report "global genital herpes treatment market" provides in-depth analysis of global genital herpes treatment market based on drug type, route of administration, distribution channel and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global genital herpes treatment market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is genital herpes treatment market growing? What will be the growth trend in the future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the genital herpes treatment market?
4-    What are the various application areas and how they are poised to grow?

Market Segmentation

By Drug Type
•    Acyclovir
•    Valacyclovir
•    Famciclovir

By Route of Administration
•    Oral
•    Topical
•    Injectable

By Distribution Channel
•    Hospital Pharmacies
•    Retail Pharmacies
•    Online Pharmacies
•    Drug Stores

By Geography
•    North America
As a part of customization
o    By Drug Type
o    By Route of administration
o    By Distribution Channel
o    US
o    Canada
o    Mexico

•    Europe
As a part of customization
o    By Drug Type
o    By Route of administration
o    By Distribution Channel
o    UK
o    Germany
o    Spain
o    Rest of Europe

•    Asia-Pacific
As a part of customization
o    By Drug Type
o    By Route of administration
o    By Distribution Channel
o    China
o    Australia
o    India
o    Rest of APAC

•    ROW
As a part of customization
o    By Drug Type
o    By Route of administration
o    By Distribution Channel
o    Brazil
o    South Africa
o    GCC countries
o    Rest of world (remaining countries of the LAMEA region)

Leading market players
•    GlaxoSmithKline
•    Genocea Biosciences
•    Teva Pharmaceuticals Inc.
•    Mylan Pharmaceuticals Inc.,
•    Apotheca Inc.,
•    Sandoz Inc.,
•    Novartis AG,
•    Hospira Inc.,
•    Novopharm Ltd.,
•    Dr. Reddy's Laboratories Ltd.

*Other prominent players in the market which can be profiled as a part of customization:
•    AiCuris
•    Vical
•    Maruho

For Sample Pages & Detailed Report Description Click  @ https://www.gmiresearch.com/report/global-genitalh-herpes...